{"entity":{"type":"insider","cik":"0001620137","url":"/insider/0001620137","json_url":"/insider/0001620137.json","name":"FROM STEPHEN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2016-09-16","last":"2019-07-15","span_basis":"filed_date"},"name_variants":[{"name":"FROM STEPHEN","source":"filing","n_filings":5,"first_seen":"2016-09-16","last_seen":"2019-07-15"}],"transactions":[{"id":8157017,"accession":"0001144204-19-034763","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-19-034763","line_url":"/filing/0001144204-19-034763#line-3","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001620137","owner_name":"FROM STEPHEN","owner_display_name":"FROM STEPHEN","owner_url":"/insider/0001620137","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42452.0,"shares_display":"42,452","price_per_share":0.233,"price_display":"0.23","price_state":"stated","total_value":9891.316,"total_display":"9,891.32","total_whole":"9,891","shares_owned_after":1032465.0,"shares_owned_after_display":"1,032,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-15","filed_date":"2019-07-15","scope":"insider"},{"id":8157014,"accession":"0001144204-19-034763","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-034763","line_url":"/filing/0001144204-19-034763#line-2","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001620137","owner_name":"FROM STEPHEN","owner_display_name":"FROM STEPHEN","owner_url":"/insider/0001620137","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42452.0,"shares_display":"42,452","price_per_share":0.2356,"price_display":"0.24","price_state":"stated","total_value":10001.6912,"total_display":"10,001.69","total_whole":"10,002","shares_owned_after":1074917.0,"shares_owned_after_display":"1,074,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-12","filed_date":"2019-07-15","scope":"insider"},{"id":8157010,"accession":"0001144204-19-034763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-034763","line_url":"/filing/0001144204-19-034763#line-1","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001620137","owner_name":"FROM STEPHEN","owner_display_name":"FROM STEPHEN","owner_url":"/insider/0001620137","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42451.0,"shares_display":"42,451","price_per_share":0.2406,"price_display":"0.24","price_state":"stated","total_value":10213.7106,"total_display":"10,213.71","total_whole":"10,214","shares_owned_after":1117369.0,"shares_owned_after_display":"1,117,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-11","filed_date":"2019-07-15","scope":"insider"},{"id":6788454,"accession":"0001144204-18-021206","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-021206","line_url":"/filing/0001144204-18-021206#line-1","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001620137","owner_name":"FROM STEPHEN","owner_display_name":"FROM STEPHEN","owner_url":"/insider/0001620137","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":409820.0,"shares_owned_after_display":"409,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-17","filed_date":"2018-04-18","scope":"insider"},{"id":5224645,"accession":"0001144204-17-042118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-042118","line_url":"/filing/0001144204-17-042118#line-1","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001620137","owner_name":"FROM STEPHEN","owner_display_name":"FROM STEPHEN","owner_url":"/insider/0001620137","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":1.03,"price_display":"1.03","price_state":"stated","total_value":12875.0,"total_display":"12,875.00","total_whole":"12,875","shares_owned_after":272465.0,"shares_owned_after_display":"272,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-10","filed_date":"2017-08-10","scope":"insider"},{"id":5142320,"accession":"0001144204-17-032552","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-032552","line_url":"/filing/0001144204-17-032552#line-1","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001620137","owner_name":"FROM STEPHEN","owner_display_name":"FROM STEPHEN","owner_url":"/insider/0001620137","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":259965.0,"shares_owned_after_display":"259,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-14","filed_date":"2017-06-14","scope":"insider"},{"id":2983173,"accession":"0001144204-16-124265","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-124265","line_url":"/filing/0001144204-16-124265#line-1","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001620137","owner_name":"FROM STEPHEN","owner_display_name":"FROM STEPHEN","owner_url":"/insider/0001620137","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":1.4892,"price_display":"1.49","price_state":"stated","total_value":22338.0,"total_display":"22,338.00","total_whole":"22,338","shares_owned_after":139965.0,"shares_owned_after_display":"139,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-15","filed_date":"2016-09-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001372514","name":"EYEGATE PHARMACEUTICALS INC","url":"/issuer/0001372514","role":"Director, Officer (President and CEO)","n_filings":5,"first_seen":"2016-09-16","last_seen":"2019-07-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001620137","retrieved_at":"2026-08-25T04:50:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}